Starace M, Pampaloni F, Carpanese Miriam A, Sechi A, Bruni F, Alessandrini A, Is a Triggering Role or a Causative Role of PD-1/PDL-1 Inhibitors in the Development of Paraneoplastic Dermatomyositis?, «DERMATOLOGY PRACTICAL & CONCEPTUAL», 2022, 12, Article number: e2022105, pp. 1 - 3 [articolo]Open Access
Starace M, Carpanese MA, Pampaloni F, Dika E, Pileri A, Rubino D, Alessandrini A, Zamagni C, Baraldi C, Misciali C, Patrizi A, Bianchi T, Apalla Z, Piraccini BM, Management of malignant cutaneous wounds in oncologic patients, «SUPPORTIVE CARE IN CANCER», 2022, 30, pp. 7615 - 7623 [articolo]Open Access
Irene Russo , Sara Cazzolla, Francesca Pampaloni, Mauro Alaibac, Omalizumab for the Treatment of Chronic Spontaneous Urticaria: Association Between Body Mass Index and Outcome, «DERMATOLOGY PRACTICAL & CONCEPTUAL», 2022, 12, pp. N/A - N/A [articolo]
Augusta Ortolan, Mariagrazia Lorenzin, Giovanni Leo, Francesca Pampaloni, Francesco Messina, Andrea Doria, Stefano Piaserico, Roberta Ramonda, Secukinumab Drug Survival in Psoriasis and Psoriatic Arthritis Patients: A 24-Month Real-Life Study, «DERMATOLOGY», 2022, 238(5), pp. 897 - 903 [articolo]
Pampaloni F, Caroppo F, Salmaso R, Belloni Fortina A., A Slowly Growing Single Plaque in an 8-year-old Girl: A Quiz, «ACTA DERMATO-VENEREOLOGICA», 2021, 101, Article number: 790, pp. 1 - 2 [articolo]Open Access
Messina F, Pampaloni F, Piaserico S., Correspondence on 'Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept. A report on a patient with COVID-19 with psoriatic arthritis receiving ustekinumab'., «ANNALS OF THE RHEUMATIC DISEASES», 2021, 80, pp. 5 - 5 [articolo]
